Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathyJoerg Halter, Michio Hirano, W. Michael et al.|Brain|2015Cited by 142
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey studyJosè Antonio Pérez-Simón, Ingrid Magnolia Parra Salinas, Cristina Calderón Cabrera et al.|Bone Marrow Transplantation|2019Cited by 90
Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante HematopoyeticoGuillermo Ortí, Rafael F. Duarte, Jaime Sanz et al.|Biology of Blood and Marrow Transplantation|2015Cited by 65
Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortiumCristina Astrid Tentori, David A. Sallman, Lin P. Zhao et al.|HemaSphere|2024Cited by 11
Allogeneic Stem Cell Transplantation As Consolidation Therapy in Patients with Relapsed-Refractory B-Cell Lymphoma Exposed to Bispecific Antibodies: A Study on Behalf of Grupo Español De Transplante y Terapia Celular (GETH-TC)Marta Peña, Alberto Mussetti, Giulia Losi et al.|Blood|2024Cited by 2